Wordt geladen...
Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models
OBJECTIVE: There is increasing pre-clinical evidence indicating that metformin, a medication commonly used for type 2 diabetes, may protect against cancer. Motivated by this emerging evidence we asked two questions: (a) can metformin prevent ovarian cancer growth by altering metabolism, and (b) will...
Bewaard in:
| Gepubliceerd in: | Am J Obstet Gynecol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2014
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4387077/ https://ncbi.nlm.nih.gov/pubmed/25446664 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajog.2014.10.026 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|